A citation-based method for searching scientific literature

Graham Pawelec. Biogerontology 2017
Times Cited: 48







List of co-cited articles
385 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Inflamm-aging. An evolutionary perspective on immunosenescence.
C Franceschi, M Bonafè, S Valensin, F Olivieri, M De Luca, E Ottaviani, G De Benedictis. Ann N Y Acad Sci 2000
25

The hallmarks of aging.
Carlos López-Otín, Maria A Blasco, Linda Partridge, Manuel Serrano, Guido Kroemer. Cell 2013
22

Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?
Tamas Fulop, Anis Larbi, Gilles Dupuis, Aurélie Le Page, Eric H Frost, Alan A Cohen, Jacek M Witkowski, Claudio Franceschi. Front Immunol 2018
341
20


Aging of the immune system: Focus on inflammation and vaccination.
Marcello Pinti, Victor Appay, Judith Campisi, Daniela Frasca, Tamas Fülöp, Delphine Sauce, Anis Larbi, Birgit Weinberger, Andrea Cossarizza. Eur J Immunol 2016
144
14

Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans.
Claudio Franceschi, Miriam Capri, Daniela Monti, Sergio Giunta, Fabiola Olivieri, Federica Sevini, Maria Panagiota Panourgia, Laura Invidia, Laura Celani, Maria Scurti,[...]. Mech Ageing Dev 2007
14

Human T cell immunosenescence and inflammation in aging.
Arsun Bektas, Shepherd H Schurman, Ranjan Sen, Luigi Ferrucci. J Leukoc Biol 2017
90
14

Age and immunity: What is "immunosenescence"?
Graham Pawelec. Exp Gerontol 2018
117
14

Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.
Jean-Philippe Coppé, Christopher K Patil, Francis Rodier, Yu Sun, Denise P Muñoz, Joshua Goldstein, Peter S Nelson, Pierre-Yves Desprez, Judith Campisi. PLoS Biol 2008
12

Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis.
Tomohiro F Nishijima, Hyman B Muss, Shlomit S Shachar, Stergios J Moschos. Cancer Treat Rev 2016
145
12

Immune checkpoint inhibitors and elderly people: A review.
Amaury Daste, Charlotte Domblides, Marine Gross-Goupil, Camille Chakiba, Amandine Quivy, Valérie Cochin, Erwan de Mones, Nicolas Larmonier, Pierre Soubeyran, Alain Ravaud. Eur J Cancer 2017
81
12


Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans.
Rafael Solana, Raquel Tarazona, Inmaculada Gayoso, Olivier Lesur, Gilles Dupuis, Tamas Fulop. Semin Immunol 2012
268
12

Markers of T Cell Senescence in Humans.
Weili Xu, Anis Larbi. Int J Mol Sci 2017
77
12

The Role of Immunosenescence in Neurodegenerative Diseases.
Erica Costantini, Chiara D'Angelo, Marcella Reale. Mediators Inflamm 2018
50
12

The senescence-associated secretory phenotype: the dark side of tumor suppression.
Jean-Philippe Coppé, Pierre-Yves Desprez, Ana Krtolica, Judith Campisi. Annu Rev Pathol 2010
12

Immunosenescence: Implications for response to infection and vaccination in older people.
Alejandra Pera, Carmen Campos, Nelson López, Fakhri Hassouneh, Corona Alonso, Raquel Tarazona, Rafael Solana. Maturitas 2015
165
10

Immunotherapy comes of age: Immune aging & checkpoint inhibitors.
Rawad Elias, Theodoros Karantanos, Elizabeth Sira, Kevan L Hartshorn. J Geriatr Oncol 2017
55
10

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
10

Lymphocyte generation and population homeostasis throughout life.
Rolando E Yanes, Claire E Gustafson, Cornelia M Weyand, Jörg J Goronzy. Semin Hematol 2017
40
12

Naive T cell maintenance and function in human aging.
Jörg J Goronzy, Fengqin Fang, Mary M Cavanagh, Qian Qi, Cornelia M Weyand. J Immunol 2015
145
10


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
10

Naive T cells: the crux of cellular immune aging?
Victor Appay, Delphine Sauce. Exp Gerontol 2014
50
10

The Role of Immunosenescence in the Development of Age-Related Diseases.
Tamas Fülöp, Gilles Dupuis, Jacek M Witkowski, Anis Larbi. Rev Invest Clin 2016
95
10

Regulatory T cells and the immune aging process: a mini-review.
Ann Jagger, Yasuhiro Shimojima, Jorg J Goronzy, Cornelia M Weyand. Gerontology 2014
136
10

Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.
Claudio Franceschi, Judith Campisi. J Gerontol A Biol Sci Med Sci 2014
10

Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer.
Chris P Verschoor, Jennie Johnstone, Jamie Millar, Michael G Dorrington, Mojtaba Habibagahi, Alina Lelic, Mark Loeb, Jonathan L Bramson, Dawn M E Bowdish. J Leukoc Biol 2013
127
8

Immunosenescence of ageing.
A L Gruver, L L Hudson, G D Sempowski. J Pathol 2007
470
8


Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
8

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Hossein Borghaei, Luis Paz-Ares, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado,[...]. N Engl J Med 2015
8

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
Achim Rittmeyer, Fabrice Barlesi, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello, Joachim von Pawel, Shirish M Gadgeel, Toyoaki Hida, Dariusz M Kowalski, Manuel Cobo Dols,[...]. Lancet 2017
8

Immunosenenescence: role of cytomegalovirus.
Graham Pawelec. Exp Gerontol 2014
95
8

Immunobiography and the Heterogeneity of Immune Responses in the Elderly: A Focus on Inflammaging and Trained Immunity.
Claudio Franceschi, Stefano Salvioli, Paolo Garagnani, Magda de Eguileor, Daniela Monti, Miriam Capri. Front Immunol 2017
83
8

Innate cell communication kick-starts pathogen-specific immunity.
Amariliz Rivera, Mark C Siracusa, George S Yap, William C Gause. Nat Immunol 2016
112
8

Molecular Determinants in Phagocyte-Bacteria Interactions.
Stefan H E Kaufmann, Anca Dorhoi. Immunity 2016
80
8

Inflamm-aging does not simply reflect increases in pro-inflammatory markers.
Vincent Morrisette-Thomas, Alan A Cohen, Tamàs Fülöp, Éléonor Riesco, Véronique Legault, Qing Li, Emmanuel Milot, Françis Dusseault-Bélanger, Luigi Ferrucci. Mech Ageing Dev 2014
93
8


Perturbed CD8+ T cell immunity across universal influenza epitopes in the elderly.
Thi H O Nguyen, Sneha Sant, Nicola L Bird, Emma J Grant, E Bridie Clemens, Marios Koutsakos, Sophie A Valkenburg, Stephanie Gras, Martha Lappas, Anthony Jaworowski,[...]. J Leukoc Biol 2018
28
14

Geroscience: linking aging to chronic disease.
Brian K Kennedy, Shelley L Berger, Anne Brunet, Judith Campisi, Ana Maria Cuervo, Elissa S Epel, Claudio Franceschi, Gordon J Lithgow, Richard I Morimoto, Jeffrey E Pessin,[...]. Cell 2014
760
8



T cell replicative senescence in human aging.
Jennifer P Chou, Rita B Effros. Curr Pharm Des 2013
168
8

Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations.
Curtis H Kugel, Stephen M Douglass, Marie R Webster, Amanpreet Kaur, Qin Liu, Xiangfan Yin, Sarah A Weiss, Farbod Darvishian, Rami N Al-Rohil, Abibatou Ndoye,[...]. Clin Cancer Res 2018
105
8

The serial cultivation of human diploid cell strains.
L HAYFLICK, P S MOORHEAD. Exp Cell Res 1961
6

Age-related changes in lymphocyte development and function.
Phyllis Jean Linton, Kenneth Dorshkind. Nat Immunol 2004
752
6

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Julie Brahmer, Karen L Reckamp, Paul Baas, Lucio Crinò, Wilfried E E Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E Vokes, Esther Holgado,[...]. N Engl J Med 2015
6

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Roy S Herbst, Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn,[...]. Lancet 2016
6

Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation.
Celine S Lages, Isabelle Suffia, Paula A Velilla, Bin Huang, Gregg Warshaw, David A Hildeman, Yasmin Belkaid, Claire Chougnet. J Immunol 2008
227
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.